Replay Therapeutics
4 known investors
Replay develops gene therapies for patients with rare genetic diseases. It operates in the biotechnology and gene therapy sector.
Founders & leadership
LM
Lachlan MacKinnonCEO and Founder
AW
Adrian WoolfsonFounder
RC
Robert CoffinExecutive Chairman
MC
Maria Castner-MillerGeneral Counsel
RM
Renata MartinVP & Head of Gene Therapy
SS
Saurabh SharmaVP & Head of CMC
SQ
Sam QuinnCorporate Controller
Investors · 4
Competitors · 2
by search overlap
AskBio6 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
Splice Bio5 shared keywordsSpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes. The company is currently in clinical stages, with its lead program targeting Stargardt Disease.
Companies competing with Replay Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Replay Therapeutics do?
- Replay develops gene therapies for patients with rare genetic diseases. It operates in the biotechnology and gene therapy sector.
- Who founded Replay Therapeutics?
- Replay Therapeutics was founded by Lachlan MacKinnon, Adrian Woolfson.
- Who are Replay Therapeutics's investors?
- Replay Therapeutics's investors include Artis Ventures, OMX Ventures, Solari Capital, Axial VC.